Shanghai BiOligo Biotech Co.
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- $47M
Investors
- 3
About Shanghai BiOligo Biotech Co.
, Ltd is a medical company that focuses on research, development and sales of in vitro diagnostic products and nucleic acid drugs. The company's mainly involved in the field of virus testing, screening of serious diseases, genetic drug development and research, forensic identification, quarantine and food safety monitoring. The core team has more than 10 years of experience in the field of test probe and primer. The company's provides industrial-grade probe or primer synthesis, DNA sequencing services, total gene synthesis services and SNP (single nucleotide polymorphism) genotyping services for customers.
Who invested in Shanghai BiOligo Biotech Co.
3 investors across 1 round
See all investors in Shanghai BiOligo Biotech Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 22, 2021
Amount
$47M
Investors
Questions about Shanghai BiOligo Biotech Co.
Who invested in Shanghai BiOligo Biotech Co.?
Shanghai BiOligo Biotech Co. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai BiOligo Biotech Co. raised?
Shanghai BiOligo Biotech Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Shanghai BiOligo Biotech Co. last raise money?
Shanghai BiOligo Biotech Co.'s most recent round on record is a Series A, in Oct 2021.
What does Shanghai BiOligo Biotech Co. do?
, Ltd is a medical company that focuses on research, development and sales of in vitro diagnostic products and nucleic acid drugs.
Where is Shanghai BiOligo Biotech Co. headquartered?
Shanghai BiOligo Biotech Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai BiOligo Biotech Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Shanghai BiOligo Biotech Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Shanghai BiOligo Biotech Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.